Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07312240) titled 'LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Istituto Auxologico Italiano
Condition:
Amyotrophic Lateral Sclerosis
Intervention:
Diagnostic Test: Lumbar Puncture for analysis of Cerebrospinal Fluid
Diagnostic Test: Deep Phenotyping
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 17, 2025
Target Sample Size: 140
Countries of Recruitment:
I...